| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $311.14M | $306.58M | $295.94M | $276.24M | $241.93M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $312.53M | $210.59M | $258.73M | $273.19M | $261.22M |
| R&D | $49.77M | $57.95M | $72.63M | $75.68M | $62.73M |
| SG&A | $49.56M | $56.82M | $76.56M | $61.70M | $85.93M |
| Operating Income | -$160.85M | -$69.81M | -$126.90M | -$140.00M | -$143.65M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $716.00K | $333.00K | $356.00K | -$4.28M | -$6.90M |
| Net Income | -$177.97M | -$69.50M | -$118.15M | -$137.40M | -$153.21M |
| EPS (basic) | -2.5500 | -1.1500 | -2.0900 | -2.5600 | -3.2300 |
| EPS (diluted) | -2.5500 | -1.1500 | -2.0900 | -2.6300 | -3.2300 |
| Shares (diluted) | $69.90M | $60.18M | $56.42M | $54.08M | $47.49M |